NEOGENOMICS, INC.

(NEO)
  Report
Delayed Nasdaq  -  04:00 2022-08-17 pm EDT
11.64 USD   -3.64%
08/16NEOGENOMICS : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PU
08/12NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
08/10BTIG Downgrades NeoGenomics to Neutral From Buy
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart NEOGENOMICS, INC.
Upcoming events on NEOGENOMICS, INC.
11/01/22 Q3 2022 Earnings Release (Projected)
02/22/23 FY 2022 Earnings Release (Projected)
05/02/23 Q1 2023 Earnings Release (Projected)
08/01/23 Interim 2023 Earnings Release (Projected)
Past events on NEOGENOMICS, INC.
08/09/22 | 08:30am Interim 2022 Earnings Call
08/09/22 | 07:00am Interim 2022 Earnings Release
06/13/22 Goldman Sachs Global Healthcare Conference
06/08/22 | 12:20pm William Blair Growth Stock Conference
06/06/22 | 02:15pm American society of clinical oncology meeting - abstract no: 9579
06/06/22 | 02:15pm American society of clinical oncology meeting - abstract no: 6052
06/06/22 | 02:15pm American society of clinical oncology meeting - abstract no: 6017
06/05/22 | 09:00am American society of clinical oncology meeting - abstract no: 3039
06/04/22 | 09:00am American Society of Clinical Oncology Meeting
06/02/22 | 10:00am Annual General Meeting
Past dividends on NEOGENOMICS, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
259
257
0,58%
277
272
1,9%
409
406
0,66%
444
443
0,44%
484
485
-0,06%
 
491
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
32,8
31,7
3,3%
43,6
39,9
9,1%
57,2
57,5
-0,45%
34,8
33,1
5,3%
-4,16
-2,03
-105%
 
-69,3
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
3,38
0,50
575%
10,0
9,77
2,7%
13,0
14,8
-12%
-14,0
-11,3
-24%
-119
-101
-17%
 
-156
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-3,48
-6,44
46%
3,82
3,10
23%
3,65
3,82
-4,5%
-14,1
-18,3
23%
-15,1
-3,98
-279%
 
-179
 
Net income
M $
Released
Forecast
Spread
-11,4
-16,5
31%
6,09
5,57
9,3%
8,01
3,52
127%
4,17
-8,48
149%
-8,35
0,68
-1 326%
 
-166
 
EPS
$
Released
Forecast
Spread
-0,14
-0,21
33%
0,07
0,06
8,9%
0,08
0,04
122%
0,04
-0,08
151%
-0,07
0,00
-4 092%
 
-1,33
 
Announcement Date02/21/201802/19/201902/27/202002/24/202102/23/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread
122
118
3,2%
121
125
-3,0%
126
126
-0,03%
117
116
0,62%
125
123
1,5%
 
123
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
4,55
0,74
511%
-3,11
-0,09
-3 254%
-9,79
-6,72
-46%
-19,0
-20,0
4,8%
-16,3
-18,8
13%
 
-18,8
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-22,4
-10,7
-109%
-39,7
-18,5
-115%
-41,6
-29,3
-42%
-52,0
-40,8
-27%
-39,7
-41,5
4,2%
 
-39,1
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
73,4
-12,6
683%
-23,2
-21,4
-8,5%
-44,2
-33,4
-32%
-53,2
-43,2
-23%
-41,0
-45,1
9,0%
 
-44,2
 
Net income
M $
Released
Forecast
Spread
75,9
-12,5
707%
-20,3
-20,4
0,43%
-41,8
-33,3
-26%
-49,4
-42,8
-15%
-35,3
-42,1
16%
 
-41,6
 
EPS
$
Released
Forecast
Spread
0,59
-0,10
666%
-0,17
-0,16
-4,4%
-0,34
-0,27
-25%
-0,40
-0,35
-16%
-0,28
-0,34
17%
 
-0,33
 
Announcement Date08/06/202111/04/202102/23/202204/27/202208/09/2022-
Previous year Next Year
Upcoming sector events for NEOGENOMICS, INC.
More events
Past sector events for NEOGENOMICS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise